|
1
|
Johnson SR, Cordier JF, Lazor R, et al:
Review Panel of the ERS LAM Task Force: European Respiratory
Society guidelines for the diagnosis and management of
lymphangioleiomyomatosis. Eur Respir J. 35:14–26. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Meraj R, Wikenheiser-Brokamp KA, Young LR
and McCormack FX: Lymphangioleiomyomatosis: new concepts in
pathogenesis, diagnosis, and treatment. Semin Respir Crit Care Med.
33:486–497. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pallisa E, Sanz P, Roman A, et al:
Lymphangioleiomyomatosis: pulmonary and abdominal findings with
pathologic correlation. Radiographics. 22:S185–S198. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Johnson S: Rare diseases. 1.
Lymphangioleiomyomatosis: clinical features, management and basic
mechanisms. Thorax. 54:254–264. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mavroudi M, Zarogoulidis P, Katsikogiannis
N, et al: Lymphangioleiomyomatosis: current and future. J Thorac
Dis. 5:74–79. 2013.PubMed/NCBI
|
|
6
|
Hancock E and Osborne J:
Lymphangioleiomyomatosis: a review of the literature. Respir Med.
96:1–6. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chu SC, Horiba K, Usuki J, et al:
Comprehensive evaluation of 35 patients with
lymphangioleiomyomatosis. Chest. 115:1041–1052. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Johnson SR: Lymphangioleiomyomatosis. Eur
Respir J. 27:1056–1065. 2006.PubMed/NCBI
|
|
9
|
Ansótegui Barrera E, Mancheño Franch N,
Vera-Sempere F and Padilla Alarcón J: Lymphangioleiomyomatosis.
Arch Bronconeumol. 47:85–93. 2011.[(In English and Spanish)].
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Almoosa KF, Ryu JH, Mendez J, et al:
Management of pneumothorax in lymphangioleiomyomatosis: effects on
recurrence and lung transplantation complications. Chest.
129:1274–1281. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Johnson SR and Tattersfield AE: Clinical
experience of lymphangioleiomyomatosis in the UK. Thorax.
55:1052–1057. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ryu JH, Doerr CH, Fisher SD, et al:
Chylothorax in lymphangioleiomyomatosis. Chest. 123:623–627. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Juvet SC, McCormack FX, Kwiatkowski DJ, et
al: Molecular pathogenesis of lymphangioleiomyomatosis: lessons
learned from orphans. Am J Respir Cell Mol Biol. 36:398–408. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koyama M, Johkoh T, Honda O, et al:
Chronic cystic lung disease: diagnostic accuracy of high-resolution
CT in 92 patients. AJR Am J Roentgenol. 180:827–835. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Taveira-DaSilva AM, Stylianou MP, Hedin
CJ, et al: Decline in lung function in patients with
lymphangioleiomyomatosis treated with or without progesterone.
Chest. 126:1867–1874. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Johnson SR and Tattersfield AE: Decline in
lung function in lymphangioleiomyomatosis: relation to menopause
and progesterone treatment. Am J Respir Crit Care Med. 160:628–633.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Avila NA, Chen CC, Chu SC, et al:
Pulmonary lymphangioleiomyomatosis: correlation of
ventilation-perfusion scintigraphy, chest radiography, and CT with
pulmonary function tests. Radiology. 214:441–446. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Taveira-DaSilva AM, Hedin C, Stylianou MP,
et al: Reversible airflow obstruction, proliferation of abnormal
smooth muscle cells, and impairment of gas exchange as predictors
of outcome in lymphangioleiomyomatosis. Am J Respir Crit Care Med.
164:1072–1076. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krymskaya VP: Smooth muscle-like cells in
pulmonary lymphangioleiomyomatosis. Proc Am Thorac Soc. 5:119–126.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu J, Astrinidis A, Howard S, et al:
Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma
cell growth and activate both genomic and nongenomic signaling
pathways. Am J Physiol Lung Cell Mol Physiol. 286:L694–L700. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao J, Zhu P, Zhang S, et al: A
clinicopathological analysis of pulmonary lymphangioleiomyomatosis.
Zhongguo Fei Ai Za Zhi. 14:378–382. 2011.[(In Chinese)]. PubMed/NCBI
|
|
22
|
Bonetti F, Chiodera PL, Pea M, et al:
Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45
for diagnosis. Am J Surg Pathol. 17:1092–1102. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meraj R, Wikenheiser-Brokamp KA, Young LR,
et al: Utility of transbronchial biopsy in the diagnosis of
lymphangioleiomyomatosis. Front Med. 4:395–405. 2012. View Article : Google Scholar
|
|
24
|
Glassberg MK, Elliot SJ, Fritz J, et al:
Activation of the estrogen receptor contributes to the progression
of pulmonary lymphangioleiomyomatosis via matrix
metalloproteinase-induced cell invasiveness. J Clin Endocrinol
Metab. 93:1625–1633. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Riojas RA, Bahr BA, Thomas DB, et al: A
case report of lymphangioleiomyomatosis presenting as spontaneous
pneumothorax. Mil Med. 177:477–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Matsui K, Beasley MB, Nelson WK, et al:
Prognostic significance of pulmonary lymphangioleiomyomatosis
histologic score. Am J Surg Pathol. 25:479–484. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Harari S, Torre O and Moss J:
Lymphangioleiomyomatosis: what do we know and what are we looking
for? Eur Respir Rev. 20:34–44. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yano S: Exacerbation of pulmonary
lymphangioleiomyomatosis by exogenous oestrogen used for
infertility treatment. Thorax. 57:1085–1086. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Johnson SR and Tattersfield AE: Clinical
experience of lymphangioleiomyomatosis in the UK. Thorax.
55:1052–1057. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fujimoto M, Ohara N, Sasaki H, et al:
Pregnancy complicatedwith pulmonary lymphangioleiomyomatosis: case
report. Clin Exp Obstet Gynecol. 32:199–200. 2005.PubMed/NCBI
|
|
31
|
Brunelli A, Catalini G and Fianchini A:
Pregnancy exacerbating unsuspected mediastinal
lymphangioleiomyomatosis and chylothorax. Int J Gynaecol Obstet.
52:289–290. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
McLoughlin L, Thomas G and Hasan K:
Pregnancy and lymphangioleiomyomatosis: anaesthetic management. Int
J Obstet Anesth. 12:40–44. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Casanova A and Ancochea J:
Lymphangioleiomyomatosis: new therapeutic approaches. Arch
Bronconeumol. 47:579–580. 2011.[(In Spanish)]. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bissler JJ, McCormack FX, Young LR, et al:
Sirolimus for angiomyolipoma in tuberous sclerosis complex or
lymphangioleiomyomotosis. N Engl J Med. 358:140–151. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Casanova A, María Girón R, Acosta O,
Barrón M, Valenzuela C and Ancochea J: Lymphangioleiomyomatosis
treatment with sirolimus. Arch Bronconeumol. 47:470–472. 2011.[(In
Spanish)]. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
McCormack FX, Inoue Y, Moss J, et al:
National Institutes of Health Rare Lung Diseases Consortium; MILES
Trial Group: Efficacy and safety of sirolimus in
lymphangioleiomyomatosis. N Engl J Med. 364:1595–1606. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kinder B and McCormack FX: Clinical trials
for rare lung diseases; lessons from lymphangioleiomyomatosis.
Lymphat Res Biol. 8:71–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
